RESTON, Va., Feb. 26, 2025 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the fiscal year ended December 31, 2024, and provided an update on the Company’s continued progress. Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, commented, “We believe 2024 was a transformative year for the nuclear industry as we saw unprecedented momentum in the adoption and development of nuclear power solutions. Throughout the year, Lightbridge continued advancing development of our nuclear fuel technology, to deliver more power for a cleaner energy future. Our focus on developing next-generation metallic fuel for water-cooled reactors positions us to address the growing demand for reliable, sustainable...

– Fourth Quarter Revenues up 10% to $304.8 Million With Net Income up 15% to $16.8 Million, or $0.63 per Diluted Share – VANCOUVER, Wash., Feb. 26, 2025 (GLOBE NEWSWIRE) — Barrett Business Services, Inc. (“BBSI” or the “Company”) (NASDAQ: BBSI), a leading provider of business management solutions, reported financial results for the fourth quarter and full year ended December 31, 2024. All share and per share amounts presented herein have been retroactively adjusted to reflect the impact of the four-for-one stock split that was distributed in the form of a stock dividend in June 2024 (the “Stock Split”). Fourth Quarter 2024 Financial Summary vs. Year-ago QuarterRevenues up 10% to $304.8 million. Gross billings up 10% to $2.25 billion. Average worksite employees (“WSEs”) up 5%. Net income up 15% to $16.8 million, or...

Topline data from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN expected by Q4 2025 Anticipate completing enrollment in the PROGRESS-AD Phase 2 clinical trial of AL101/GSK4527226 in participants with early Alzheimer’s disease by mid-2025 Applying Alector Brain Carrier to advance therapeutic candidates, including those targeting amyloid beta and replacing GCase $413.4 million in cash, cash equivalents and investments provide runway through 2026 Management to host conference call and webcast today at 4:30 p.m. ET/1:30 p.m. PT SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today reported fourth quarter and full year 2024 financial...

DELAWARE, Ohio, Feb. 26, 2025 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, today announced fiscal first quarter 2025 results. Fiscal First Quarter 2025 Financial Highlights: (all results compared to the first quarter of 2024 unless otherwise noted)Net income decreased 87.2% to $8.6 million or $0.15 per diluted Class A share compared to net income of $67.2 million or $1.17 per diluted Class A share, primarily due to a non-recurring income tax benefit of $48.1 million in the prior year quarter. Net income, excluding the impact of adjustments(1), decreased 69.1% to $22.5 million or $0.39 per diluted Class A share compared to net income, excluding the impact of adjustments, of $72.7 million or $1.27 per diluted Class A share. Adjusted EBITDA(2) increased 5.9% to...

Record full year subscription revenue of $99.6 million, up 14% year-over-year Q4 annualized recurring revenue (ARR) grows to $104.2 million Record full year total revenue of $169.7 million Total subscribers grew to 1.2 million, up 23% year-over-yearSUNNYVALE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) — Matterport, Inc. (Nasdaq: MTTR) (“Matterport” or the “Company”), the leading spatial data company driving the digital transformation of the built world, today announced financial results for the quarter and year ended December 31, 2024. “I’m pleased to share our fourth quarter and full year 2024 results, highlighting our continued success driving efficient growth while doubling down on innovation. Total square feet digitized and managed reached a significant company milestone of 50.7 billion, up 33% year-over-year, with annual recurring...

PURCHASE, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the full year ended December 31, 2024 (“Full Year 2024”) and three months ended December 31, 2024 (“Fourth Quarter 2024”). Unless otherwise noted, percentage and other changes are relative to the full year ended December 31, 2023 (“Full Year 2023”) and three months ended December 31, 2023 (“Fourth Quarter 2023”). Full Year and Fourth Quarter 2024 HighlightsFull Year 2024 revenue of $2,569.6 million, down 1% year-over-year, and Fourth Quarter 2024 revenue of $640.5 million, down 3% year-over-year Full Year 2024 net loss of $1,001.2 million, or $5.87 per share, and Fourth Quarter 2024 net loss of $48.4 million, or $0.28 per share Full Year 2024 adjusted EBITDA of...

Good profitability and cash flow generationdespite slower growth in 2024 2024 key figuresRevenue: €2,441 million (+2.1% compared to 2023)organic growth: +1.3% external growth: +2.3%Operating margin rate: 13.1% Free cash flow generation: €216 millionBen Page, CEO of Ipsos, stated: “Despite slowing growth, the improvement in gross margin and careful cost management enabled us to deliver a good level of profitability. Ipsos’ financial health is also reflected in strong cash generation, virtually debt-free status and Investment Grade ratings by Moody’s and Fitch. Our recent acquisitions have cemented our leadership in Public Affairs and Data Analytics. Finally, we will continue to invest in our panels, platforms and Generative AI to deliver even faster cutting-edge insights to our clients.” Paris, 26 February 2025 – Ipsos, one of...

       2024 Full-Year Results: a very active year, a dual model in place, strong value creation & a growing return to shareholders Fully diluted1 Net Asset Value per share of €185.7, representing a +16.9% year-over-year value creation, adjusted for the dividend paid Dividend boosted at €4.7 per share, up +17.5% year-over-year Strong portfolio rotation: more than €2 billion of capital reallocation Significant expansion of the Asset Management platform in Europe and US, and development of our dual business model towards more recurring cash flows and growth Fully diluted Net Asset Value2 as of December 31, 2024: €185.7 per share, up +14.4%Value creation of +16.9%3 over 2024, adjusted for the €4 dividend paid in May 2024 reflecting:The increase in Bureau Veritas’ share price (+28.3% YoY) on the back of the quality of its LEAP |...

Banco Comercial Português, S.A. informs about consolidated earnings in 2024 AttachmentsEarnings Millennium BCP FY24_finalEarningsPres 12M24

Ivry-sur-Seine, February 26, 2025, 5:45 p.m. CET STRONG 2024 ANNUAL RESULTS, TARGETS EXCEEDED1 RELEVANCE OF THE TRANSFORMATION DRIVEN BY THE STRATEGIC PLAN EVERYDAYEUROPEAN LEADERSHIP STRENGTHENED WITH THE ACQUISITION OF UNIEURO SALES GROWTH AND MARKET OUTPERFORMANCE1Revenue: +1% to nearly €8bn Growth in omnichannel sales: +1.7 points, 52% of the Group’s online sales  Increased market share at major end-of-year commercial eventsGROWTH IN GROSS MARGIN AND 2024 CURRENT OPERATING INCOME TARGET ACHIEVED1Gross margin at 30.6% (vs. 30.2% in 2023), driven by Services, which contributed +50 bps Current operating income: €182m (+6% vs. 2023): proof of the effectiveness of the performance plans implemented in all departments2021–2024 CUMULATIVE FREE CASH-FLOW FROM OPERATIONS: TARGET EXCEEDED1€195m generated in 2024, an increase of...